Over 10,000 results
Page 15 of 100
8-K
990xm
17 Jun 24
Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051
8:45am
8-K
zgxkxcmba3e1qjby50f
17 Jun 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:44am
6-K
ccm2t5650zuhvb4 ee
17 Jun 24
Transaction In Own Shares
8:43am
13F-HR
ii73v8
17 Jun 24
Quarterly holdings report by institutional manager
8:43am
424B3
9exhzkgq6
17 Jun 24
Prospectus supplement
8:42am
8-K
5bgeioqyhqt eq
17 Jun 24
Xponential Fitness Announces Appointment of Mark King as Chief Executive Officer
8:40am
SC 14D9
40fwzc
17 Jun 24
Tender offer solicitation
8:38am
8-K
65n9ux0uxj
17 Jun 24
Departure of Directors or Certain Officers
8:38am
424B2
v2pop99534488bj
17 Jun 24
Prospectus for primary offering
8:37am
6-K
n9953d 5nky
17 Jun 24
Current report (foreign)
8:36am
8-K
w3e6pap7mf fl8
17 Jun 24
AV-101 did not meet the primary endpoint of change in pulmonary vascular resistance (PVR) for any of the studied doses
8:35am
424B5
don5jutt9 vjfqs5
17 Jun 24
Prospectus supplement for primary offering
8:33am
8-K
btt0 b0dop
17 Jun 24
Submission of Matters to a Vote of Security Holders
8:32am
8-K
tdaue3w5
17 Jun 24
Cheniere Declares Quarterly Dividend
8:31am
SC TO-I/A
j60ge85ja3jdfpkg
17 Jun 24
Issuer tender offer statement (amended)
8:30am
424B5
3jxwha68 90ipmu
17 Jun 24
Prospectus supplement for primary offering
8:30am
8-K
2cwovu
17 Jun 24
Atara Biotherapeutics Announces 1-for-25 Reverse Stock Split
8:30am
6-K
mebp9hninusi ug
17 Jun 24
Current report (foreign)
8:30am
8-K
d249q
17 Jun 24
Departure of Directors or Certain Officers
8:30am